Annex tables to the European Drug Report 2024
These tables, produced specifically for the European Drug Report 2024, provide national data for estimates of drug use prevalence including problem opioid use, substitution treatment, total number in treatment, treatment entry, injecting drug use, drug-induced deaths, drug-related infectious diseases, syringe distribution and drug seizures. The data are drawn from and are a subset of the EMCDDA Statistical Bulletin 2024, where notes and meta-data are available. The years to which data refer are indicated. In addition, for some indicators, these data tables also provide total values for EU as well as for EMCDDA reporting countries, 'EU+2' (EU Member States, Türkiye and Norway).
This page is part of the European Drug Report 2024, the EMCDDA's annual overview of the drug situation in Europe.
Last update: 11 June 2024
List of tables
- Opioids
- Table 1a. High-risk opioid use estimates for population aged 15–64 years
- Table 1b. Entrants into treatment during the year: opioids clients as a proportion of treatment demands
- Table 1c. Entrants into treatment during the year: proportion of opioids clients with injection as main route of administration
- Table 1d. Number of clients in opioid agonist treatment
- Cocaine
- Table 2a. Cocaine prevalence estimates among the general population and school students
- Table 2b. Entrants into treatment during the year - cocaine clients as a proportion of treatment demands
- Table 2c. Entrants into treatment during the year: proportion of cocaine clients with injection as main route of administration
- Amphetamines
- Table 3a. Amphetamines prevalence estimates among the general population and school students
- Table 3b. Entrants into treatment during the year - amphetamines clients as a proportion of treatment demands
- Table 3c. Entrants into treatment during the year: proportion of amphetamines clients with injection as main route of administration
- MDMA
- Cannabis
- Other indicators
- Seizures
Opioids
Country | Year of estimate | cases per 1 000 |
---|---|---|
Belgium | ‒ | ‒ |
Bulgaria | ‒ | ‒ |
Czechia | 2022 | 1.4-1.4 |
Denmark | 2016 | 4.0-9.6 |
Germany | 2021 | 1.6-2.0 |
Estonia | ‒ | ‒ |
Ireland | 2019 | 6.6-7.3 |
Greece | 2022 | 1.0-1.5 |
Spain | 2021 | 1.2-2.2 |
France | 2020 | 5.5-5.8 |
Croatia | 2015 | 2.5-4.0 |
Italy | 2022 | 3.6-6.0 |
Cyprus | 2022 | 1.8-3.8 |
Latvia | 2017 | 4.6-7.0 |
Lithuania | 2016 | 2.7-6.5 |
Luxembourg | 2019 | 3.3 |
Hungary | 2010-11 | 0.4-0.5 |
Malta | 2022 | 3.6-3.7 |
Netherlands | 2012 | 1.1-1.5 |
Austria | 2021 | 6.3-6.8 |
Poland | 2014 | 0.4-0.7 |
Portugal | 2018 | 3.0-7.0 |
Romania | 2020 | 1.0-1.7 |
Slovenia | 2022 | 3.0-3.5 |
Slovakia | 2020 | 0.9–1.7 |
Finland | 2017 | 6.9-8.6 |
Sweden | ‒ | ‒ |
Türkiye | 2011 | 0.2-0.5 |
Norway | 2013 | 2.0-4.2 |
Notes
High-risk opioid use estimates relate to the population aged 15 to 64 years.
Country | All opioids entrants - % | All opioids entrants - count | First-time opioids entrants - % | First-time opioids entrants - count | Previously treated opioids entrants - % | Previously treated opioids entrants - count |
---|---|---|---|---|---|---|
Belgium | 16.9 | 1897 | 5.5 | 216 | 23 | 1543 |
Bulgaria | 58.1 | 627 | 24.9 | 84 | 74.2 | 517 |
Czechia | 37.7 | 2747 | 18.7 | 470 | 36.8 | 1229 |
Denmark | 11.7 | 682 | 7.9 | 206 | 14.9 | 446 |
Germany | 14.6 | 5914 | 7.2 | 1601 | 24.2 | 3869 |
Estonia | 65.7 | 274 | 43.5 | 54 | 74.8 | 217 |
Ireland | 33.1 | 3808 | 13.4 | 597 | 46.8 | 2970 |
Greece | 46.7 | 1659 | 26.1 | 398 | 62.1 | 1247 |
Spain | 19.2 | 8518 | 10.5 | 2463 | 29.6 | 5428 |
France | 24.4 | 8637 | 15.2 | 2497 | 42.8 | 4155 |
Croatia | 61.4 | 1421 | 21.5 | 138 | 76.6 | 1283 |
Italy | 35.6 | 12395 | 22.6 | 3105 | 44.1 | 9290 |
Cyprus | 19.1 | 169 | 15.5 | 83 | 26.3 | 81 |
Latvia | 35.7 | 263 | 18.8 | 71 | 53.5 | 192 |
Lithuania | 80.9 | 347 | 34.1 | 15 | 88.9 | 305 |
Luxembourg | 33.6 | 85 | 22.2 | 20 | 39.9 | 65 |
Hungary | 2.2 | 96 | 1.1 | 31 | 6.1 | 58 |
Malta | 47.7 | 919 | 25.9 | 121 | 54.8 | 798 |
Netherlands | 11.5 | 1262 | 6.2 | 402 | 19.3 | 860 |
Austria | 46.4 | 1941 | 30.7 | 514 | 56.8 | 1427 |
Poland | 16 | 680 | 7.8 | 161 | 24.4 | 511 |
Portugal | 33.9 | 1183 | 17.7 | 338 | 53.6 | 845 |
Romania | 21.1 | 777 | 8.5 | 206 | 45.9 | 571 |
Slovenia | 78.9 | 105 | 56.2 | 18 | 85.7 | 84 |
Slovakia | 13.8 | 292 | 7.8 | 70 | 20.4 | 218 |
Finland | 39.1 | 167 | 40.2 | 66 | 38.4 | 101 |
Sweden | 31.8 | 122 | 14.9 | 1973 | - | - |
Türkiye | 44.3 | 5041 | 33.9 | 2312 | 60.1 | 2729 |
Norway | 18.2 | 1154 | 12.2 | 377 | 22.5 | 817 |
European Union | 24.1 | 56987 | 12.7 | 15918 | 36.1 | 38310 |
EU, Türkiye and Norway | 24.9 | 63182 | 13.8 | 18607 | 36.6 | 41856 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
(2) Norway: The percentage of clients in treatment for opioid-related problems is a minimum value, not accounting for opioid clients registered as polydrug users.
Country | All opioids entrants - % | All opioids entrants - count | First-time opioids entrants - % | First-time opioids entrants - count | Previously treated opioids entrants - % | Previously treated opioids entrants - count |
---|---|---|---|---|---|---|
Belgium | 12.7 | 219 | 6.3 | 13 | 13.8 | 194 |
Bulgaria | 64.9 | 386 | 57.7 | 45 | 66.6 | 333 |
Czechia | 61.7 | 1059 | 56.8 | 246 | 63.5 | 704 |
Denmark | 8.9 | 56 | 3.6 | 7 | 12 | 49 |
Germany | 18.4 | 751 | 13.7 | 154 | 20 | 524 |
Estonia | 76.2 | 205 | 75.9 | 41 | 76.4 | 162 |
Ireland | 28.9 | 1071 | 17.6 | 105 | 29.7 | 862 |
Greece | 23.4 | 385 | 16.9 | 67 | 25.4 | 316 |
Spain | 9.4 | 747 | 4.8 | 115 | 11.4 | 604 |
France | 12.2 | 953 | 8.2 | 190 | 15.4 | 599 |
Croatia | 61.3 | 849 | 30 | 39 | 64.5 | 810 |
Italy | 39.9 | 4255 | 24.4 | 594 | 44.5 | 3661 |
Cyprus | 40.1 | 67 | 34.9 | 29 | 47.5 | 38 |
Latvia | 78 | 188 | 73 | 46 | 79.8 | 142 |
Lithuania | 80 | 268 | 73.3 | 11 | 79.9 | 235 |
Luxembourg | 50.6 | 42 | 45 | 9 | 52.4 | 33 |
Hungary | 29.2 | 26 | 16.7 | 5 | 35.1 | 20 |
Malta | 44.9 | 412 | 17.4 | 21 | 49.1 | 391 |
Netherlands | 6.1 | 39 | 7.6 | 13 | 5.6 | 26 |
Austria | 24.8 | 396 | 17.6 | 70 | 27.2 | 326 |
Poland | 44.8 | 303 | 36.7 | 58 | 47 | 240 |
Portugal | 10.8 | 117 | 8.3 | 25 | 11.8 | 92 |
Romania | 81.1 | 597 | 74.5 | 149 | 83.6 | 448 |
Slovenia | 28.8 | 30 | 11.8 | 2 | 29.8 | 25 |
Slovakia | 67.5 | 195 | 64.3 | 45 | 68.4 | 147 |
Finland | 76.4 | 126 | 75.8 | 50 | 76.8 | 76 |
Sweden | 61.8 | 68 | - | - | - | - |
Türkiye | 19.2 | 969 | 14.6 | 338 | 23.1 | 631 |
Norway | - | - | - | - | - | - |
European Union | 27.9 | 13810 | 17.7 | 2149 | 32.1 | 11057 |
EU, Türkiye and Norway | 27.1 | 14779 | 17.2 | 2487 | 31.5 | 11688 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
Missing cases of 30 % or more for main route of administration: Czechia, Germany and the Netherlands.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
(2) Norway: the percentage of clients in treatment for opioid-related problems is a minimum value, not accounting for opioid clients registered as polydrug users.
Country | Count |
---|---|
Belgium | 15324 |
Bulgaria | 2850 |
Czechia | 7500 |
Denmark | 5719 |
Germany | 81200 |
Estonia | 950 |
Ireland | 11667 |
Greece | 8940 |
Spain | 55633 |
France | 177100 |
Croatia | 4596 |
Italy | 75711 |
Cyprus | 292 |
Latvia | 700 |
Lithuania | 1078 |
Luxembourg | 1291 |
Hungary | 526 |
Malta | 857 |
Netherlands | 5241 |
Austria | 20644 |
Poland | 4010 |
Portugal | 16839 |
Romania | 1728 |
Slovenia | 3056 |
Slovakia | 673 |
Finland | 4729 |
Sweden | 4417 |
Türkiye | 5041 |
Norway | 7643 |
European Union | 513271 |
EU, Türkiye and Norway | 525955 |
Notes
Data on clients in agonist treatment are for 2022 or most recent year available: Spain, 2021; Finland, 2019; France, Italy, 2018; Netherlands, 2015.
(1) Czechia: number of clients in agonist treatment is an estimate derived from the treatment demand register and opioid agonist treatment provided by general practitioners.
(2) Netherlands: Data on the number of clients in agonist treatment are not complete.
Cocaine
Country | Year of survey | General population surveys - lifetime, all adults (15-64) | General population surveys - last 12 months, young adults (15-34) | School surveys - lifetime, students (15-16) |
---|---|---|---|---|
Belgium | 2018 | ‒ | 2.9 | 1.4 |
Bulgaria | 2020 | 2 | 1.3 | 3 |
Czechia | 2021 | 1.4 | 0.7 | 2 |
Denmark | 2023 | 9.4 | 4.2 | 2 |
Germany | 2021 | 5.6 | 3.1 | 1 |
Estonia | 2018 | 5 | 2.8 | 2 |
Ireland | 2019 | 8.3 | 4.8 | 3 |
Greece | 2015 | 1.3 | 0.6 | 1 |
Spain | 2022 | 12 | 3.1 | 2 |
France | 2017 | 5.58 | 3.18 | 3 |
Croatia | 2019 | 4.8 | 3.9 | 2 |
Italy | 2022 | 6.6 | 2.1 | 2 |
Cyprus | 2022 | 2.2 | 1.1 | 4 |
Latvia | 2020 | 2.7 | 2.2 | 2 |
Lithuania | 2021 | 1.8 | 0.8 | 2 |
Luxembourg | 2019 | 2.9 | 0.9 | 2 |
Hungary | 2019 | 1.7 | 0.6 | 3 |
Malta | 2022 | 0.5 | 2 | |
Netherlands | 2022 | 7.8 | 5.5 | 2 |
Austria | 2018 | 6.2 | 2.2 | 2 |
Poland | 2022 | 0.7 | 0.5 | 2 |
Portugal | 2019 | 1.1 | 0.5 | 2 |
Romania | 2018 | 1.6 | 0.7 | 2 |
Slovenia | 2023 | 2.7 | 1.8 | 3 |
Slovakia | 2022 | 2.1 | 1.1 | 1 |
Finland | 2022 | 5.8 | 3.1 | 1 |
Sweden (1) | 2017 | ‒ | 2.8 | 0.7 |
Türkiye | 2022 | 0.168 | 0.082 | ‒ |
Norway | 2021 | 7.3 | 4.2 | 2 |
European Union | ‒ | 5.4 | 2.5 | ‒ |
EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18-64 and 18-34 for Germany, Greece, France, Italy and Hungary; 16-64 and 16-34 for Denmark, Estonia and Norway; 18-65 for Malta; 17-34 for Sweden.Germany ESPAD data refer to Bavaria only.
Country | All cocaine entrants - % | All cocaine entrants - count | First-time cocaine entrants - % | First-time cocaine entrants - count | Previously treated cocaine entrants - % | Previously treated cocaine entrants - count |
---|---|---|---|---|---|---|
Belgium | 30.8 | 3444 | 28.4 | 1115 | 31.4 | 2111 |
Bulgaria | 7.8 | 84 | 11 | 37 | 5.7 | 40 |
Czechia | 0.9 | 62 | 1.1 | 28 | 1 | 32 |
Denmark | 24 | 1397 | 24.8 | 648 | 23.6 | 705 |
Germany | 9.4 | 3817 | 9.4 | 2076 | 9.4 | 1511 |
Estonia | 3.1 | 13 | 3.2 | 4 | 3.1 | 9 |
Ireland | 33.7 | 3872 | 41.3 | 1838 | 27.9 | 1770 |
Greece | 19.9 | 707 | 23.2 | 354 | 17.5 | 351 |
Spain | 46.8 | 20741 | 45.3 | 10647 | 49 | 9004 |
France | 11.8 | 4174 | 11.6 | 1911 | 13.1 | 1273 |
Croatia | 5.2 | 121 | 11.9 | 76 | 2.7 | 45 |
Italy | 40.6 | 14132 | 44.1 | 6055 | 38.3 | 8077 |
Cyprus | 26.1 | 231 | 23.4 | 125 | 31.2 | 96 |
Latvia | 1.8 | 13 | 2.1 | 8 | 1.4 | 5 |
Lithuania | 3.7 | 16 | 15.9 | 7 | 2 | 7 |
Luxembourg | 23.7 | 60 | 14.4 | 13 | 28.8 | 47 |
Hungary | 5.5 | 244 | 6 | 172 | 3.9 | 37 |
Malta | 39 | 750 | 54.3 | 254 | 34 | 496 |
Netherlands | 24.3 | 2675 | 20.8 | 1357 | 29.6 | 1318 |
Austria | 15.6 | 654 | 18.1 | 304 | 13.9 | 350 |
Poland | 3.4 | 145 | 3.5 | 72 | 3.3 | 70 |
Portugal | 26.4 | 922 | 29.8 | 569 | 22.4 | 353 |
Romania | 3.9 | 144 | 5 | 121 | 1.8 | 23 |
Slovenia | 12 | 16 | 31.2 | 10 | 6.1 | 6 |
Slovakia | 1.3 | 28 | 2 | 18 | 0.8 | 9 |
Finland | 0.7 | 3 | 1.2 | 2 | 0.4 | 1 |
Sweden | 3.6 | 14 | 3.9 | 517 | - | - |
Türkiye | 2.9 | 327 | 3 | 206 | 2.7 | 121 |
Norway | 5 | 316 | 6 | 186 | 3.6 | 130 |
European Union | 24.7 | 58479 | 22.6 | 28338 | 26.1 | 27746 |
EU, Türkiye and Norway | 23.3 | 59122 | 21.2 | 28730 | 24.5 | 27997 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
Country | All cocaine entrants - % | All cocaine entrants - count | First-time cocaine entrants - % | First-time cocaine entrants - count | Previously treated cocaine entrants - % | Previously treated cocaine entrants - count |
---|---|---|---|---|---|---|
Belgium | 3.3 | 98 | 1.4 | 13 | 4.3 | 80 |
Bulgaria | 2.7 | 2 | 0 | 0 | 5.7 | 2 |
Czechia | 5 | 3 | 3.7 | 1 | 6.5 | 2 |
Denmark | 0.9 | 11 | 0.3 | 2 | 1.4 | 9 |
Germany | 1.8 | 49 | 0.9 | 13 | 2.9 | 30 |
Estonia | 38.5 | 5 | 50 | 2 | 33.3 | 3 |
Ireland | 0.7 | 28 | - | - | 1.4 | 24 |
Greece | 5.9 | 42 | 2 | 7 | 10 | 35 |
Spain | 0.7 | 134 | 0.4 | 39 | 1.1 | 94 |
France | 4.7 | 186 | 1.9 | 34 | 8.7 | 105 |
Croatia | 1.7 | 2 | 1.4 | 1 | 2.3 | 1 |
Italy | 1.8 | 230 | 1 | 53 | 2.4 | 177 |
Cyprus | 7 | 16 | 7.3 | 9 | 7.3 | 7 |
Latvia | 0 | 0 | 0 | 0 | 0 | 0 |
Lithuania | - | - | - | - | - | - |
Luxembourg | 43.1 | 25 | 9.1 | 1 | 51.1 | 24 |
Hungary | 2.5 | 6 | 1.8 | 3 | 5.7 | 2 |
Malta | 5.6 | 42 | 1.6 | 4 | 7.7 | 38 |
Netherlands | 0.4 | 5 | 0.1 | 1 | 0.6 | 4 |
Austria | 5.7 | 35 | 2.1 | 6 | 8.9 | 29 |
Poland | 1.4 | 2 | 1.4 | 1 | 1.4 | 1 |
Portugal | 1.6 | 14 | 0.7 | 4 | 2.9 | 10 |
Romania | 0 | 0 | 0 | 0 | 0 | 0 |
Slovenia | 18.8 | 3 | 10 | 1 | 33.3 | 2 |
Slovakia | 3.6 | 1 | - | - | 11.1 | 1 |
Finland | 0 | 0 | 0 | 0 | 0 | 0 |
Sweden | 8.3 | 1 | - | - | - | - |
Türkiye | 0 | 0 | 0 | 0 | - | - |
Norway | - | - | - | - | - | - |
European Union | 1.8 | 940 | 0.8 | 199 | 2.7 | 680 |
EU, Türkiye and Norway | 1.8 | 940 | 0.8 | 199 | 2.7 | 680 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
Missing cases of 30 % or more for main route of administation: Germany and the Netherlands.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
Amphetamines
Country | Year of survey | General population surveys - lifetime, all adults (15-64) | General population surveys - last 12 months, young adults (15-34) | School surveys - lifetime, students (15-16) |
---|---|---|---|---|
Belgium | 2018 | ‒ | 0.8 | 1.2 |
Bulgaria | 2020 | 2.1 | 1.4 | 3 |
Czechia | 2021 | 1.8 | 0.3 | 1 |
Denmark | 2023 | 7.9 | 1 | 1 |
Germany | 2021 | 6.1 | 2.9 | 2 |
Estonia | 2018 | 6.1 | 2.1 | 3 |
Ireland | 2019 | 4.8 | 2.3 | 2 |
Greece | ‒ | ‒ | ‒ | 1 |
Spain | 2022 | 4.6 | 1.1 | 1 |
France | 2017 | 2.17 | 0.6 | 1 |
Croatia | 2019 | 4.6 | 3.5 | 2 |
Italy | 2022 | 2.2 | 1.3 | 1 |
Cyprus | 2022 | 0.9 | 0.9 | 2 |
Latvia | 2020 | 1.8 | 1.2 | 2 |
Lithuania | 2021 | 1.4 | 0.6 | 1 |
Luxembourg | 2019 | 1.3 | 0.3 | 1 |
Hungary | 2019 | 1.5 | 0.8 | 3 |
Malta | 2013 | 0.3 | ‒ | 1 |
Netherlands | 2022 | 6.3 | 3.2 | 1 |
Austria | 2022 | 4.5 | 1.4 | 2 |
Poland | 2018 | 2.4 | 1.4 | 3 |
Portugal | 2016 | 0.4 | 0 | 2 |
Romania | 2019 | 0.2 | 0.1 | 1 |
Slovenia | 2018 | 2.3 | 1.1 | 1 |
Slovakia | 2023 | 1.3 | 0.1 | 1 |
Finland | 2018 | 4.7 | 3 | 2 |
Sweden (1) | 2021 | ‒ | 1.6 | 0.8 |
Türkiye | 2017 | 0.033 | ‒ | ‒ |
Norway | 2022 | 5.2 | 0.7 | 2 |
European Union | ‒ | 3.5 | 1.5 | ‒ |
EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18-64 and 18-34 for Germany, Greece, France, Italy and Hungary; 16-64 and 16-34 for Denmark, Estonia and Norway; 18-65 for Malta; 17-34 for Sweden.Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2014). Germany ESPAD data refer to Bavaria only.
Country | All amphetamines entrants - % | All amphetamines entrants - count | First-time amphetamines entrants - % | First-time amphetamines entrants - count | Previously treated amphetamines entrants - % | Previously treated amphetamines entrants - count |
---|---|---|---|---|---|---|
Belgium | 8.9 | 994 | 6.2 | 244 | 10.9 | 735 |
Bulgaria | 16.1 | 174 | 28.5 | 96 | 10.5 | 73 |
Czechia | 41.5 | 3026 | 51.6 | 1299 | 43 | 1435 |
Denmark | 6 | 347 | 4.9 | 127 | 7 | 210 |
Germany | 14.9 | 6021 | 11.9 | 2632 | 19.7 | 3156 |
Estonia | 21.1 | 88 | 38.7 | 48 | 13.8 | 40 |
Ireland | 0.8 | 87 | 1.2 | 52 | 0.5 | 31 |
Greece | 1.5 | 54 | 1.8 | 27 | 1.3 | 27 |
Spain | 2.2 | 996 | 2.4 | 568 | 2.2 | 401 |
France | 0.7 | 241 | 0.7 | 115 | 0.6 | 55 |
Croatia | 5.3 | 123 | 11.7 | 75 | 2.9 | 48 |
Italy | 0.3 | 109 | 0.5 | 63 | 0.2 | 46 |
Cyprus | 15.6 | 138 | 13.5 | 72 | 20.8 | 64 |
Latvia | 22 | 162 | 24.9 | 94 | 18.9 | 68 |
Lithuania | 3.7 | 16 | 13.6 | 6 | 1.5 | 5 |
Luxembourg | - | - | - | - | - | - |
Hungary | 13.4 | 591 | 14 | 401 | 11.2 | 107 |
Malta | 0.2 | 3 | 0.4 | 2 | 0.1 | 1 |
Netherlands | 7.4 | 817 | 7.5 | 487 | 7.4 | 330 |
Austria | 6.2 | 260 | 6.9 | 116 | 5.7 | 144 |
Poland | 34.7 | 1476 | 38.7 | 802 | 30.8 | 646 |
Portugal | 0.3 | 10 | 0.5 | 9 | 0.1 | 1 |
Romania | 3.6 | 131 | 3.9 | 94 | 3 | 37 |
Slovenia | 0.8 | 1 | 0 | 0 | 1 | 1 |
Slovakia | 52.6 | 1115 | 56.7 | 512 | 51.3 | 548 |
Finland | 30.9 | 132 | 25 | 41 | 34.6 | 91 |
Sweden | 31 | 119 | 10.4 | 1373 | ||
Türkiye | 39.3 | 4466 | 47.5 | 3246 | 26.9 | 1220 |
Norway | 13.4 | 848 | 8.4 | 260 | 16.2 | 588 |
European Union | 7.3 | 17231 | 7.5 | 9355 | 7.8 | 8300 |
EU, Türkiye and Norway | 8.9 | 22545 | 9.5 | 12861 | 8.8 | 10108 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
Data on entrants into treatment for Sweden and Norway are for ‘stimulants other than cocaine’.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
Country | All amphetamines entrants - % | All amphetamines entrants - count | First-time amphetamines entrants - % | First-time amphetamines entrants - count | Previously treated amphetamines entrants - % | Previously treated amphetamines entrants - count |
---|---|---|---|---|---|---|
Belgium | 9.7 | 81 | 6.9 | 14 | 10.7 | 67 |
Bulgaria | 2 | 3 | 1.2 | 1 | 3.3 | 2 |
Czechia | 65.2 | 1827 | 62.5 | 779 | 67 | 933 |
Denmark | 1.8 | 6 | 0 | 0 | 2.1 | 4 |
Germany | 1.8 | 65 | 1.4 | 24 | 2.3 | 39 |
Estonia | 71.6 | 63 | 66.7 | 32 | 77.5 | 31 |
Ireland | 25 | 21 | 19.6 | 10 | 27.6 | 8 |
Greece | 13.2 | 7 | 11.5 | 3 | 14.8 | 4 |
Spain | 3.1 | 30 | 4.1 | 23 | 1.5 | 6 |
France | 3.2 | 7 | 5.5 | 6 | 3.6 | 2 |
Croatia | 0 | 0 | 0 | 0 | 0 | 0 |
Italy | 2.2 | 2 | - | - | 5 | 2 |
Cyprus | 10.5 | 14 | 7 | 5 | 15 | 9 |
Latvia | 42.4 | 59 | 33.3 | 26 | 54.1 | 33 |
Lithuania | 6.7 | 1 | - | - | - | - |
Luxembourg | - | - | - | - | - | - |
Hungary | 3.5 | 20 | 2 | 8 | 11.4 | 12 |
Malta | - | - | - | - | - | - |
Netherlands | 1.3 | 4 | 1 | 2 | 1.9 | 2 |
Austria | 1.7 | 4 | 1.9 | 2 | 1.5 | 2 |
Poland | 1.3 | 19 | 0.6 | 5 | 2.2 | 14 |
Portugal | 22.2 | 2 | 12.5 | 1 | 100 | 1 |
Romania | 0 | 0 | 0 | 0 | 0 | 0 |
Slovenia | 0 | 0 | 0 | 0 | 0 | 0 |
Slovakia | 23.5 | 257 | 20.6 | 104 | 25.5 | 137 |
Finland | 78.6 | 99 | 59.5 | 22 | 86.5 | 77 |
Sweden | 62.5 | 65 | - | - | - | - |
Türkiye | 1.2 | 53 | 0.8 | 27 | 2.1 | 26 |
Norway | - | - | - | - | - | - |
European Union | 19.5 | 2656 | 16.4 | 1067 | 21.6 | 1385 |
EU, Türkiye and Norway | 15 | 2709 | 11.2 | 1094 | 18.5 | 1411 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
Data on entrants into treatment for Sweden and Norway are for ‘stimulants other than cocaine’.
Missing cases of 30 % or more for main route of admininstration: Germany and the Netherlands.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
MDMA
Country | Year of survey | General population surveys - lifetime, all adults (15-64) | General population surveys - last 12 months, young adults (15-34) | School surveys - lifetime, students (15-16) |
---|---|---|---|---|
Belgium | 2018 | ‒ | 2.5 | 1.8 |
Bulgaria | 2020 | 1.3 | 0.7 | 3 |
Czechia | 2022 | 8.1 | 4.7 | 4 |
Denmark | 2023 | 5 | 1.1 | 2 |
Germany | 2021 | 5.6 | 2.7 | 2 |
Estonia | 2018 | 5.4 | 2.5 | 5 |
Ireland | 2019 | 10.3 | 6.5 | 3 |
Greece | 2015 | 0.6 | 0.4 | 1 |
Spain | 2022 | 5.1 | 1.8 | 1 |
France | 2017 | 3.86 | 1.31 | 2 |
Croatia | 2019 | 4.2 | 2.6 | 2 |
Italy | 2022 | 3.8 | 2.1 | 1 |
Cyprus | 2022 | 2.4 | 1.8 | 3 |
Latvia | 2020 | 1.9 | 1.6 | 5 |
Lithuania | 2021 | 1.8 | 0.8 | 3 |
Luxembourg | 2019 | 2 | 0.9 | 1 |
Hungary | 2019 | 2.5 | 1.1 | 3 |
Malta | 2013 | 0.7 | – | 1 |
Netherlands | 2022 | 12.7 | 9.8 | 3 |
Austria | 2022 | 4.9 | 1.5 | 3 |
Poland | 2018 | 1 | 0.5 | 3 |
Portugal | 2022 | 0.9 | 0.3 | 3 |
Romania | 2019 | 1 | 0.8 | 1 |
Slovenia | 2018 | 2.9 | 1.3 | 3 |
Slovakia | 2023 | 4.9 | 2.1 | 3 |
Finland | 2022 | 6.8 | 2.5 | 1 |
Sweden (1) | 2021 | ‒ | 2 | 1.1 |
Türkiye | 2017 | 0.353 | 0.159 | ‒ |
Norway | 2022 | 4.7 | 1.2 | 2 |
European Union | ‒ | 4.3 | 2.2 | ‒ |
EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18-64 and 18-34 for Germany, Greece, France, Italy and Hungary; 16-64 and 16-34 for Denmark, Estonia and Norway; 18-65 for Malta; 17-34 for Sweden.Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2014). Germany ESPAD data refer to Bavaria only.
Country | All mdma entrants - % | All mdma entrants - count | First-time mdma entrants - % | First-time mdma entrants - count | Previously treated mdma entrants - % | Previously treated mdma entrants - count |
---|---|---|---|---|---|---|
Belgium | 0.3 | 35 | 0.7 | 26 | 0.1 | 8 |
Bulgaria | 1.4 | 15 | 2.7 | 9 | 0.9 | 6 |
Czechia | 0.5 | 33 | 0.7 | 18 | 0.3 | 9 |
Denmark | 0.2 | 13 | 0.3 | 9 | 0 | 1 |
Germany | 0.5 | 183 | 0.6 | 130 | 0.3 | 44 |
Estonia | - | - | - | - | - | - |
Ireland | 0.1 | 16 | 0.3 | 12 | - | - |
Greece | 0.3 | 10 | 0.2 | 3 | 0.3 | 7 |
Spain | 0.2 | 91 | 0.3 | 68 | 0.1 | 19 |
France | 0.4 | 138 | 0.4 | 61 | 0.4 | 35 |
Croatia | 0.4 | 9 | 1.1 | 7 | 0.1 | 2 |
Italy | 0.1 | 42 | 0.1 | 14 | 0.1 | 28 |
Cyprus | 0.1 | 1 | 0.2 | 1 | - | - |
Latvia | 0.8 | 6 | 1.1 | 4 | 0.6 | 2 |
Lithuania | - | - | - | - | - | - |
Luxembourg | - | - | - | - | - | - |
Hungary | 3.1 | 135 | 3 | 87 | 2.6 | 25 |
Malta | 0.4 | 8 | 1.3 | 6 | 0.1 | 2 |
Netherlands | 0.7 | 80 | 1 | 67 | 0.3 | 13 |
Austria | 0.8 | 33 | 1 | 16 | 0.7 | 17 |
Poland | 0.3 | 11 | 0.2 | 5 | 0.3 | 6 |
Portugal | 0.5 | 19 | 0.9 | 17 | 0.1 | 2 |
Romania | 1.9 | 70 | 2.3 | 57 | 1 | 13 |
Slovenia | 0 | 0 | 0 | 0 | 0 | 0 |
Slovakia | 0.1 | 3 | 0.2 | 2 | - | - |
Finland | 0 | 0 | 0 | 0 | 0 | 0 |
Sweden | - | - | - | - | - | - |
Türkiye | 0.6 | 64 | 0.6 | 38 | 0.6 | 26 |
Norway | - | - | - | - | - | - |
European Union | 0.4 | 951 | 0.5 | 619 | 0.2 | 242 |
EU, Türkiye and Norway | 0.4 | 1015 | 0.5 | 657 | 0.2 | 268 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
Cannabis
Country | Year of survey | General population surveys - lifetime, all adults (15-64) | General population surveys - last 12 months, young adults (15-34) | School surveys - lifetime, students (15-16) |
---|---|---|---|---|
Belgium | 2018 | 22.6 | 13.6 | 17.3 |
Bulgaria | 2020 | 8.7 | 5.9 | 17 |
Czechia | 2022 | 30.4 | 13.5 | 28 |
Denmark | 2023 | 37.6 | 12.5 | 17 |
Germany | 2021 | 34.7 | 17.2 | 22 |
Estonia | 2018 | 24.5 | 16.6 | 20 |
Ireland | 2019 | 24.4 | 13.8 | 19 |
Greece | 2015 | 11 | 4.5 | 8 |
Spain | 2022 | 40.9 | 19.1 | 23 |
France | 2021 | 47.3 | 19.2 | 23 |
Croatia | 2019 | 22.9 | 20.3 | 21 |
Italy | 2022 | 34.8 | 21.5 | 27 |
Cyprus | 2022 | 18 | 10.6 | 8 |
Latvia | 2020 | 15 | 8.2 | 26 |
Lithuania | 2021 | 13.7 | 8.8 | 18 |
Luxembourg | 2019 | 23.3 | 12 | 19 |
Hungary | 2019 | 6.1 | 3.4 | 13 |
Malta | 2013 | 4.3 | – | 12 |
Netherlands | 2022 | 28.8 | 18.2 | 22 |
Austria | 2020 | 22.7 | 11.1 | 21 |
Poland | 2018 | 12.1 | 7.8 | 21 |
Portugal | 2022 | 12.2 | 4.9 | 13 |
Romania | 2019 | 6.1 | 6 | 9 |
Slovenia | 2018 | 20.7 | 12.3 | 23 |
Slovakia | 2023 | 23.1 | 10.2 | 24 |
Finland | 2022 | 31.2 | 15.1 | 11 |
Sweden (1) | 2022 | 17.8 | 6.6 | 5.1 |
Türkiye | 2017 | 2.725 | 1.846 | ‒ |
Norway | 2022 | 27.1 | 11 | 9 |
European Union | ‒ | 29.9 | 15 | ‒ |
EU, Türkiye and Norway | ‒ | ‒ | ‒ | ‒ |
Notes
Prevalence estimates for the general population: age ranges are 18-64 and 18-34 for Germany, Greece, France, Italy and Hungary; 16-64 and 16-34 for Denmark, Estonia, Sweden and Norway; 18-65 for Malta.
Prevalence estimates for the school population are extracted from the 2019 ESPAD survey, except for Belgium (2019; Flanders only) and Luxembourg (2018). Germany ESPAD data refer to Bavaria only. Due to possible overstating, Luxembourg cannabis lifetime prevalence may be slightly overestimated.
Country | All cannabis entrants - % | All cannabis entrants - count | First-time cannabis entrants - % | First-time cannabis entrants - count | Previously treated cannabis entrants - % | Previously treated cannabis entrants - count |
---|---|---|---|---|---|---|
Belgium | 31.3 | 3501 | 47.1 | 1850 | 22.7 | 1524 |
Bulgaria | 10.1 | 109 | 19.6 | 66 | 6 | 42 |
Czechia | 14.7 | 1072 | 21.4 | 539 | 14.1 | 469 |
Denmark | 53.1 | 3085 | 57.2 | 1493 | 49.2 | 1473 |
Germany | 57.4 | 23228 | 67.6 | 14981 | 43.2 | 6921 |
Estonia | 6.2 | 26 | 8.9 | 11 | 5.2 | 15 |
Ireland | 19 | 2184 | 32.8 | 1463 | 10.3 | 650 |
Greece | 27.8 | 989 | 44.9 | 684 | 14.9 | 299 |
Spain | 27.8 | 12350 | 36.3 | 8529 | 17.2 | 3160 |
France | 55.9 | 19758 | 64.9 | 10680 | 37.6 | 3647 |
Croatia | 20.6 | 478 | 44.9 | 288 | 11.4 | 190 |
Italy | 21.6 | 7516 | 30.5 | 4194 | 15.8 | 3322 |
Cyprus | 38.5 | 340 | 46.9 | 251 | 21.4 | 66 |
Latvia | 32.7 | 241 | 43.7 | 165 | 21.2 | 76 |
Lithuania | 5.8 | 25 | 25 | 11 | 3.2 | 11 |
Luxembourg | 42.7 | 108 | 63.3 | 57 | 31.3 | 51 |
Hungary | 62.4 | 2743 | 66.1 | 1895 | 51.2 | 488 |
Malta | 12.1 | 233 | 17.5 | 82 | 10.4 | 151 |
Netherlands | 47.3 | 5202 | 55.5 | 3625 | 35.4 | 1577 |
Austria | 26.8 | 1124 | 39.8 | 666 | 18.2 | 458 |
Poland | 27.4 | 1165 | 31.3 | 648 | 23.4 | 490 |
Portugal | 35.5 | 1238 | 46.9 | 896 | 21.7 | 342 |
Romania | 53.8 | 1976 | 66.1 | 1606 | 29.7 | 370 |
Slovenia | 3.8 | 5 | 9.4 | 3 | 2 | 2 |
Slovakia | 24.3 | 514 | 27.7 | 250 | 17.4 | 186 |
Finland | 14.5 | 62 | 22 | 36 | 9.9 | 26 |
Sweden | 11.2 | 43 | 13.7 | 1816 | - | - |
Türkiye | 8.3 | 946 | 9.8 | 669 | 6.1 | 277 |
Norway | 26.9 | 1707 | 31.4 | 970 | 20.3 | 737 |
European Union | 37.8 | 89315 | 45.3 | 56785 | 24.5 | 26006 |
EU, Türkiye and Norway | 36.2 | 91968 | 43.2 | 58424 | 23.6 | 27020 |
Notes
Data on entrants into treatment are for 2022 or most recent year available: Czechia, 2020; Spain, France, Finland, 2021; Netherlands, 2015.
(1) Sweden: data on all treatment entrants include exclusively compulsory institutional care. In previous years data included treatment entrants from hospital-based treatment, compulsory institutional care, as well as prison and probation services. First-time entrants refers to clients who received hospital-based treatment only. Data shown are not fully representative of the national picture.
Other indicators
Country | Drug-induced deaths - Year | Drug-induced deaths - All ages - Count | Drug-induced deaths - Cases per million population - Aged 15-64 | Drug-induced deaths - Aged 15-64 - Count | HIV diagnoses related to injecting drug use (ECDC) - Cases per million population (a) | HIV diagnoses related to injecting drug use (ECDC) - Count (a) | Injecting drug use estimate - Year of estimate | Injecting drug use estimate - Cases per 1 000 population | Syringes distributed through specialised programmes |
---|---|---|---|---|---|---|---|---|---|
Belgium | 2020 | 172 | 21 | 152 | 3.2 | 37 | 2019 | 0.5-1.0 | 1176600 |
Bulgaria | 2022 | 20 | 4 | 18 | 2.6 | 18 | 2020 | 2.1-2.4 | 2880 |
Czechia | 2022 | 64 | 9 | 59 | 5.7 | 60 | 2022 | 6.2-6.4 | 9165153 |
Denmark | 2021 | 184 | 40 | 148 | 3.1 | 18 | ‒ | ‒ | – |
Germany | 2022 | 1631 | 30 | 1604 | 3.2 | 270 | ‒ | ‒ | 4197853 |
Estonia | 2022 | 82 | 95 | 80 | 3.8 | 5 | 2015 | 9.0-11.3 | 1647628 |
Ireland | 2020 | 322 | 97 | 314 | 5.9 | 30 | ‒ | ‒ | 506019 |
Greece | 2020 | 230 | 34 | 228 | 6.4 | 67 | 2022 | 0.3-0.6 | 785788 |
Spain | 2021 | 820 | 21 | 654 | 1.2 | 55 | 2021 | 0.1-0.3 | 1209503 |
France | 2017 | 417 | - | - | 1.1 | 77 | 2020 | 2.6-2.8 | 12572530 |
Croatia | 2022 | 102 | 42 | 102 | 0.8 | 3 | 2015 | 1.8-2.9 | 223348 |
Italy | 2022 | 298 | 8 | 295 | 1.4 | 82 | 2021 | 2.1-3.5 | 515445 |
Cyprus | 2022 | 5 | 8 | 5 | 2.2 | 2 | 2022 | 1.2-2.5 | 12516 |
Latvia | 2022 | 63 | 53 | 63 | 18.7 | 35 | 2016 | 5.3-6.8 | 976504 |
Lithuania | 2022 | 87 | 47 | 86 | 11.4 | 32 | 2016 | 4.4-4.9 | 480142 |
Luxembourg | 2022 | 8 | 18 | 8 | 18.6 | 12 | 2019 | 1.9 | 425133 |
Hungary | 2021 | 42 | 6 | 41 | 0.3 | 3 | 2015 | 1 | 39925 |
Malta | 2021 | 5 | 14 | 5 | 0 | 0 | ‒ | ‒ | 76666 |
Netherlands | 2022 | 332 | 26 | 299 | 0.3 | 5 | 2015 | 0.07-0.09 | – |
Austria | 2022 | 248 | 42 | 247 | 1.2 | 11 | ‒ | ‒ | 6484667 |
Poland | 2021 | 289 | 8 | 197 | 0.8 | 30 | ‒ | ‒ | 99525 |
Portugal | 2021 | 81 | 11 | 73 | 1.9 | 20 | 2015 | 1.0-4.5 | 1115452 |
Romania | 2022 | 27 | 2 | 25 | 2.2 | 42 | ‒ | ‒ | 522665 |
Slovenia | 2022 | 66 | 46 | 62 | 0 | 0 | ‒ | ‒ | 514000 |
Slovakia | 2021 | 28 | 7 | 27 | 1.7 | 9 | ‒ | ‒ | 27788 |
Finland | 2022 | 250 | 70 | 240 | 5.9 | 33 | 2017 | 7.4 | 6917325 |
Sweden | 2022 | 519 | 70 | 452 | 1.1 | 12 | ‒ | ‒ | 476244 |
Türkiye | 2022 | 246 | 4 | 243 | 0.2 | 17 | ‒ | ‒ | – |
Norway | 2022 | 321 | 86 | 303 | 4.4 | 24 | 2021 | 1.9-2.4 | 3500000 |
EU27 | 6392 | 22.5 | 5484 | 2.2 | 968 | ‒ | ‒ | – | |
EU27, Türkiye and Norway | 6959 | 19.8 | 6030 | 1.9 | 1009 | ‒ | ‒ | – |
Notes
Data on drug-induced deaths must be interpreted with caution. Methodological differences should be considered when comparing between countries. In the case of France, the age band is not specified, and the 417 cases were not included in the calculations of mortality rate referring to the population aged 15 to 64 years.
HIV diagnoses related to injecting drug use are from 2022.
Injecting drug use estimates refer to the population aged 15 to 64 years.
Syringes distributed through specialised programmes refer to 2022, except for Spain (2021), Hungary (2021), Germany (2018; not all sites covered), France (2018) and Italy (2017; data from about half of all sites).
Seizures of drugs
Country | Heroin - Quantity seized (kg) | Heroin - Quantity seized (count) | Cocaine - Quantity seized (kg) | Cocaine - Quantity seized (count) | Amphetamine - Quantity seized (kg) | Amphetamine - Quantity seized (count) | Methamphetamine - Quantity seized (kg) | Methamphetamine - Quantity seized (count) | MDMA, MDA, MDEA - Quantity seized (tablets) | MDMA, MDA, MDEA - Quantity seized kg) | MDMA, MDA, MDEA - Quantity seized (count) | Cannabis resin - Quantity seized (kg) | Cannabis resin - Quantity seized (count) | Herbal cannabis - Quantity seized (kg) | Herbal cannabis - Quantity seized (count) | Cannabis oil - Quantity seized (kg) | Cannabis oil - Quantity seized (litre) | Cannabis oil - Quantity seized (count) | Cannabis plants - Quantity seized (plants) | Cannabis plants - Quantity seized (kg) | Cannabis plants - Quantity seized (count) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium | 1283 | 4 | 110911 | 189 | 4 | 6 | 16 | 6 | - | - | - | 2833 | 13 | 2990 | 30 | - | < 1 | 4 | - | - | - |
Bulgaria | 335 | 289 | 33 | 294 | 29 | 764 | 46 | 1212 | 1332 | 4 | 149 | 4 | 32 | 15224 | 3474 | - | - | - | 25262 | 5428 | 281 |
Czechia | < 1 | 82 | 1195 | 215 | 3 | 70 | 42 | 2558 | 18854 | 2 | 258 | 2 | 70 | 927 | 6288 | - | < 1 | 1 | 15671 | - | 375 |
Denmark | - | - | 352 | 5461 | 365 | 1968 | 13 | 318 | 28204 | 8 | 536 | 5073 | 17196 | 497 | 3065 | - | 5 | 85 | 6585 | 295 | 360 |
Germany | 1023 | - | 20047 | - | 1631 | - | 785 | - | - | 236 | - | 2845 | - | 16914 | - | - | - | - | 152409 | - | - |
Estonia | < 0.01 | 2 | 3103 | 184 | 40 | 373 | < 1 | 43 | - | 1 | 102 | 39 | 20 | 68 | 676 | - | - | - | - | 39 | 37 |
Ireland (1) | - | 1635 | - | 4020 | - | 333 | - | 60 | - | - | 378 | - | 294 | - | 6429 | - | - | - | - | - | 635 |
Greece | 140 | 2428 | 900 | 1096 | 92 | 10 | 57 | 405 | 7886 | 21 | 104 | 78 | 356 | 6186 | 7598 | 433 | - | 19 | 44544 | - | 537 |
Spain | 189 | 8981 | 58334 | 53413 | 307 | 4070 | 148 | 738 | 469766 | 321 | 6390 | 324709 | 191637 | 126002 | 141082 | 9 | - | 235 | 2812950 | - | 3044 |
France | 1400 | - | 27700 | - | 273 | - | - | - | 1543421 | - | - | 87600 | - | 41000 | - | - | - | - | 76807 | - | - |
Croatia | 28 | 135 | 329 | 649 | 96 | 1094 | < 1 | 12 | - | 11 | 410 | 38 | 352 | 1140 | 5902 | - | - | - | 11658 | - | 212 |
Italy | 548 | 1464 | 26089 | 7474 | 9 | 95 | 44 | 155 | 9224 | 11 | 225 | 13900 | 8866 | 33105 | 5604 | 18 | 10 | 46 | 209057 | - | 869 |
Cyprus | < 0.1 | 14 | 38 | 134 | < 0.1 | 2 | 4 | 220 | 166 | 1 | 12 | 39 | 19 | 348 | 752 | - | - | - | 136 | - | 19 |
Latvia | < 0.01 | 3 | 175 | 150 | 11 | 370 | 9 | 171 | 7118 | 5 | 234 | 584 | 84 | 170 | 1096 | < 0.1 | - | 4 | - | 65 | 31 |
Lithuania | 1 | 44 | 23 | - | 95 | - | 2 | - | 48 | 53 | - | 1 | - | 220 | - | - | - | - | - | - | - |
Luxembourg | 4 | 80 | 1 | 189 | < 1 | 8 | < 1 | 3 | 19 | < 0.1 | 7 | 12 | 492 | 9 | 323 | - | - | - | 367 | - | 10 |
Hungary | 6 | 31 | 85 | 320 | 30 | 839 | 1 | 204 | 46627 | 4 | 462 | 18 | 155 | 522 | 2804 | 5 | - | 33 | 6366 | - | 170 |
Malta | 20 | 15 | 2971 | 57 | < 1 | 1 | - | - | 10 | - | 3 | < 1 | 3 | 157 | 42 | - | - | - | 70 | - | 5 |
Netherlands (1) | 2611 | - | 51447 | - | 32 | - | 82 | - | - | 363 | - | 293 | - | 5492 | - | - | - | - | - | - | - |
Austria | 102 | 1061 | 119 | 1986 | 29 | 904 | 10 | 550 | 20982 | 8 | 690 | 70 | 1248 | 1685 | 12360 | 3 | - | 56 | 24224 | - | 441 |
Poland | 14 | 356 | 309 | 590 | 1823 | 12038 | 107 | 2041 | 67908 | 65 | 1443 | 380 | 572 | 7280 | 20501 | - | - | - | 41086 | - | 1341 |
Portugal | 73 | 1252 | 16533 | 2010 | 1 | 105 | 2 | 19 | 7925 | 6 | 605 | 23375 | 4741 | 1157 | 1026 | < 0.1 | < 1 | 8 | 9273 | < 0.1 | 247 |
Romania | 191 | 373 | 80 | 646 | 15 | 302 | < 1 | 15 | 45355 | 2 | 635 | 13 | 191 | 608 | 3889 | - | < 1 | 4 | - | 653 | 97 |
Slovenia | 6 | 296 | 678 | 310 | 1 | 140 | 1 | 48 | 110 | < 0.1 | 48 | 2 | 78 | 688 | 2848 | - | - | - | 15119 | < 0.01 | 114 |
Slovakia | < 1 | 38 | 6 | 46 | < 0.1 | 3 | 6 | 776 | 394 | < 0.1 | 52 | 276 | 28 | 83 | 919 | < 0.1 | - | 1 | 542 | - | 20 |
Finland | < 1 | 9 | 56 | 301 | 304 | 1208 | 9 | 153 | 60683 | 9 | 383 | 286 | 167 | 753 | 1026 | - | - | - | 12703 | - | 979 |
Sweden | 18 | 613 | 1002 | 4471 | 1886 | 6553 | 7 | 155 | 128408 | 21 | 1380 | 5678 | 16054 | 2143 | 6446 | 10 | - | 263 | - | - | - |
Türkiye | 7957 | 17503 | 2276 | 3827 | 5995 | 3463 | 15827 | 77765 | 5050325 | - | 4519 | 29332 | 15729 | 42519 | 57454 | - | 116 | 29 | 109575459 | - | 5737 |
Norway | 84 | 424 | 117 | 1501 | 199 | 2715 | 30 | 136 | 43658 | 14 | 580 | 3971 | 5261 | 1172 | 2148 | 1 | 5 | - | - | - | - |
European Union | 7991 | 19205 | 322516 | 84205 | 7076 | 31256 | 1392 | 9862 | 2464440 | 1152 | 14506 | 468149 | 242668 | 265372 | 234180 | 478 | 17 | 759 | 3464829 | 6478 | 9824 |
EU, Türkiye and Norway | 16032 | 37132 | 324909 | 89533 | 13270 | 37434 | 17250 | 87763 | 7558423 | 1166 | 19605 | 501451 | 263658 | 309063 | 293782 | 479 | 139 | 788 | 113037288 | 6478 | 15561 |
Notes
(1)All data are for 2022 or the most recent year submitted by the Reitox national focal points and are rounded off to the most significant figures.
(1) Data on number and quantity of seizures for some countries do not include all relevant law enforcement units and should be considered partial, minimum figures. See below:
Dutch Customs: Only cannabis resin and herbal quantities seized.
(2) Amphetamine (including captagon) and methamphetamine tablets were converted to mass-equivalents by assuming a mass of 0.25 grams per tablet.
Methamphetamine: methamphetamine/methylamphetamine
Source data
The data used to create these tables may be found in CSV format below.
The complete set of source data for the European Drug Report 2024 including metadata and methodological notes is available in our data catalogue.
A subset of this data used to generate the tables on this page, may be found below.